A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes

Iwamoto, 2007, TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses, J Immunol, 179, 1449, 10.4049/jimmunol.179.3.1449

Jongstra-Bilen, 2006, Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis, J Exp Med, 203, 2073, 10.1084/jem.20060245

Xu, 2005, Differentiation to the CCR2+ inflammatory phenotype in vivo is a constitutive, time-limited property of blood monocytes and is independent of local inflammatory mediators, J Immunol, 175, 6915, 10.4049/jimmunol.175.10.6915

Taylor, 2003, Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis, Cell Death Differ, 10, 418, 10.1038/sj.cdd.4401152

Chen, 2009, Synergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein-coupled receptor, in microglial cells, J Neuroimmunol, 213, 69, 10.1016/j.jneuroim.2009.05.018

Pais, 2008, Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway, J Neuroinflammation, 5, 43, 10.1186/1742-2094-5-43

Sasahara, 2008, Activation of bone marrow-derived microglia promotes photoreceptor survival in inherited retinal degeneration, Am J Pathol, 172, 1693, 10.2353/ajpath.2008.080024

Croce, 2009, Myeloid-related protein-8/14 is critical for the biological response to vascular injury, Circulation, 120, 427, 10.1161/CIRCULATIONAHA.108.814582

Soehnlein, 2009, Myeloid cells in atherosclerosis: initiators and decision shapers, Semin Immunopathol, 31, 35, 10.1007/s00281-009-0141-z

Nygren, 2008, Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion, Nat Cell Biol, 10, 584, 10.1038/ncb1721

Boyd, 2008, S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products, Circ Res, 102, 1239, 10.1161/CIRCRESAHA.107.167544

Beekhuizen, 1991, CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells, J Immunol, 147, 3761, 10.4049/jimmunol.147.11.3761

Qu, 2009, Myeloid-specific expression of Api6/AIM/Sp alpha induces systemic inflammation and adenocarcinoma in the lung, J Immunol, 182, 1648, 10.4049/jimmunol.182.3.1648

Medoff, 2009, CD11b+ myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation, J Immunol, 182, 623, 10.4049/jimmunol.182.1.623

Deng, 2009, Immature myeloid cells induced by a high-fat diet contribute to liver inflammation, Hepatology, 50, 1412, 10.1002/hep.23148

Strom, 2009, Obesity, weight gain, and risk of chronic myeloid leukemia, Cancer Epidemiol Biomarkers Prev, 18, 1501, 10.1158/1055-9965.EPI-09-0028

Nguyen, 2007, A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways, J Biol Chem, 282, 35279, 10.1074/jbc.M706762200

Tzima, 2009, Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production, J Exp Med, 206, 1167, 10.1084/jem.20081582

King, 2009, Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease, Blood, 113, 3190, 10.1182/blood-2008-07-168575

Dominguez-Soto, 2007, Myeloid dendritic cell lectins and their role in immune responses, Curr Opin Investig Drugs, 8, 910

Zhu, 2007, CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis, J Immunol, 179, 5228, 10.4049/jimmunol.179.8.5228

McKinlay, 2007, Blood monocytes, myeloid dendritic cells and the cytokines interleukin (IL)-7 and IL-15 maintain human CD4+ T memory cells with mixed helper/regulatory function, Immunology, 120, 392, 10.1111/j.1365-2567.2006.02515.x

Ostrand-Rosenberg, 2009, Myeloid-derived suppressor cells: linking inflammation and cancer, J Immunol, 182, 4499, 10.4049/jimmunol.0802740

Gonzalez-Mejia, 2009, Regulation of monocytes and macrophages cell fate, Front Biosci, 14, 2413, 10.2741/3387

Bunt, 2009, Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through toll-like receptor 4, J Leukoc Biol, 85, 996, 10.1189/jlb.0708446

Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol, 9, 162, 10.1038/nri2506

Sinha, 2007, Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells, Cancer Res, 67, 4507, 10.1158/0008-5472.CAN-06-4174

Bunt, 2006, Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression, J Immunol, 176, 284, 10.4049/jimmunol.176.1.284

Xiang, 2009, Induction of myeloid-derived suppressor cells by tumor exosomes, Int J Cancer, 124, 2621, 10.1002/ijc.24249

Iero, 2008, Tumour-released exosomes and their implications in cancer immunity, Cell Death Differ, 15, 80, 10.1038/sj.cdd.4402237

Bhatnagar, 2007, Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo, Blood, 110, 3234, 10.1182/blood-2007-03-079152

Yu, 2007, Tumor exosomes inhibit differentiation of bone marrow dendritic cells, J Immunol, 178, 6867, 10.4049/jimmunol.178.11.6867

Valenti, 2007, Tumor-released microvesicles as vehicles of immunosuppression, Cancer Res, 67, 2912, 10.1158/0008-5472.CAN-07-0520

Ravindran, 2009, Curcumin and cancer cells: how many ways can curry kill tumor cells selectively, AAPS J, 11, 495, 10.1208/s12248-009-9128-x

Anand, 2008, Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature, Biochem Pharmacol, 76, 1590, 10.1016/j.bcp.2008.08.008

Dhillon, 2008, Phase II trial of curcumin in patients with advanced pancreatic cancer, Clin Cancer Res, 14, 4491, 10.1158/1078-0432.CCR-08-0024

Anand, 2008, Curcumin and cancer: an “old-age” disease with an “age-old” solution, Cancer Lett, 267, 133, 10.1016/j.canlet.2008.03.025

Aggarwal, 2009, Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases, Int J Biochem Cell Biol, 41, 40, 10.1016/j.biocel.2008.06.010

Anand, 2007, Bioavailability of curcumin: problems and promises, Mol Pharm, 4, 807, 10.1021/mp700113r

Mulik, 2009, Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: physicochemical characterization and stability study, Eur J Pharm Sci, 37, 395, 10.1016/j.ejps.2009.03.009

Shaikh, 2009, Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer, Eur J Pharm Sci, 37, 223, 10.1016/j.ejps.2009.02.019

Narayanan, 2009, Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice, Int J Cancer, 125, 1, 10.1002/ijc.24336

Yadav, 2009, Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease, J Pharm Pharmacol, 61, 311, 10.1211/jpp.61.03.0005

Cui, 2009, Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems, Int J Pharm, 371, 148, 10.1016/j.ijpharm.2008.12.009

Chen, 2009, An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells, Int J Pharm, 366, 133, 10.1016/j.ijpharm.2008.09.009

Choi, 2009, Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots, Nano Lett, 9, 2354, 10.1021/nl900872r

Bisht, 2007, Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy, J Nanobiotechnology, 5, 3, 10.1186/1477-3155-5-3

Li, 2005, Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis, Cancer, 104, 1322, 10.1002/cncr.21300

Li, 2009, A rapid and simple HPLC method for the determination of curcumin in rat plasma: assay development, validation and application to a pharmacokinetic study of curcumin liposome, Biomed Chromatogr, 23, 1201, 10.1002/bmc.1244

Epstein, 2010, Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies, Br J Nutr, 10.1017/S0007114509993667